title: Silent subtype 3 carcinoma of the pituitary: a case report.
authors.forename: F
authors.initials: F
authors.lastname: Roncaroli
authors.forename: B W
authors.initials: BW
authors.lastname: Scheithauer
authors.forename: E
authors.initials: E
authors.lastname: Horvath
authors.forename: D
authors.initials: D
authors.lastname: Erickson
authors.forename: C K
authors.initials: CK
authors.lastname: Tam
authors.forename: R V
authors.initials: RV
authors.lastname: Lloyd
authors.forename: K
authors.initials: K
authors.lastname: Kovacs
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D046529:Microscopy, Electron, Transmission; D019635:Neurosurgical Procedures; D015282:Octreotide / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000503:physiopathology* / Q000628:therapy / Q000648:ultrastructure*; D011878:Radiotherapy
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide